Human medicines European public assessment report (EPAR): Pramipexole Accord, pramipexole, Date of authorisation: 29/09/2011, Revision: 10, Status: Withdrawn
Veterinary medicines European public assessment report (EPAR): Innovax-ILT-IBD, turkey herpes virus, expressing infectious bursal disease virus and avian infectious laryngotracheitis virus, strain HVT/IBD/ILT, live, Status: Authorised
Veterinary medicines European public assessment report (EPAR): Prevexxion RN+HVT, Marek’s disease virus, strain RN1250, live,Turkey herpesvirus, strain FC126, Live, Status: Authorised
Veterinary medicines European public assessment report (EPAR): Eurican L4, inactivated immunological veterinary medicinal product containing Leptospira interrogans, serogroup Canicola, serovar Canicola, strain 16070, L. interrogans, serogroup icterohaemorrhagiae, serovar icterohaemorrhagiae, strain 16069, L. interrogans, serogroup Grippotyphosa, serovar Grippotyphosa, strain Grippo Mal 1540, L. interrogans, serogroup Australis, serovar Bratislava, strain, Status: Authorised
Herbal medicinal product: Symphyti radixArray, F: Assessment finalised
Agenda of the COMP meeting 12-14 March 2024
Committee for Medicinal Products for Human Use (CHMP): 22-25 January 2024, European Medicines Agency, Amsterdam, the Netherlands, from 22 January 2024 to 25 January 2024
Product-specific bioequivalence guidance
Minutes of the CHMP meeting 22-25 January 2024
Procedural advice for orphan medicinal product designation: Guidance for sponsors